In the last twelve months, the biggest single purchase by an insider was when CEO, President & Director Andrew Hirsch bought US$84k worth of shares at a price of US$8.40 per share. View our latest analysis for C4 Therapeutics The Last 12 Months Of Insider Transactions At C4 Therapeutics
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
Put another way, the original US$84k acquisition is now worth US$102k. The stock rose 12%, resulting in a US$55m rise in the company's market capitalisation.
( NASDAQ:CCCC) insiders who bought shares over the past year were rewarded handsomely last week.
0 kommentar(er)
